| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Oxford Lipid Metabolism Group, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford, United Kingdom OX2 6HE; the Department of Physiology and Pharmacology, Medical School, Queens Medical Center (I.A.M.), Nottingham, United Kingdom NG7 2UH; and the Unit of Metabolic Medicine, Imperial College School of Medicine at St. Marys (P.A.B.), London, United Kingdom W2 1PG
Address all correspondence and requests for reprints to: Dr. Keith N. Frayn, Oxford Lipid Metabolism Group, Radcliffe Infirmary, Oxford, OX2 6HE United Kingdom. E-mail: keith.frayn{at}oxlip.ox.ac.uk
Cortisol is known to increase whole body lipolysis, yet chronic hypercortisolemia results in increased fat mass. The main aim of the study was to explain these two apparently opposed observations by examining the acute effects of hypercortisolemia on lipolysis in subcutaneous adipose tissue and in the whole body. Six healthy subjects were studied on two occasions. On one occasion hydrocortisone sodium succinate was infused iv to induce hypercortisolemia (mean plasma cortisol concentrations, 1500 ± 100 vs. 335 ± 25 nmol/L; P < 0.001); on the other occasion (control study) no intervention was made.
Lipolysis in the sc adipose tissue of the anterior abdominal wall was studied by measurement of arterio-venous differences, and lipolysis in the whole body was studied by constant infusion of [1,2,3-2H5]glycerol for measurement of the systemic glycerol appearance rate. Hypercortisolemia led to significantly increased arterialized plasma nonesterified fatty acid (NEFA; P < 0.01) and blood glycerol concentrations (P < 0.05), with an increase in systemic glycerol appearance (P < 0.05). However, in sc abdominal adipose tissue, hypercortisolemia decreased veno-arterialized differences for NEFA (P < 0.05) and reduced NEFA efflux (P < 0.05). This reduction was attributable to decreased intracellular lipolysis (P < 0.05), reflecting decreased hormone-sensitive lipase action in this adipose depot. Hypercortisolemia caused a reduction in arterialized plasma TAG concentrations (P < 0.05), but without a significant change in the local extraction of TAG (presumed to reflect the action of adipose tissue lipoprotein lipase). There was no significant difference in plasma insulin concentrations between the control and hypercortisolemia study. Site-specific regulation of the enzymes of intracellular lipolysis (hormone-sensitive lipase) and intravascular lipolysis (lipoprotein lipase) may explain the ability of acute cortisol treatment to increase systemic glycerol and NEFA appearance rates while chronically promoting net central fat deposition.
This article has been cited by other articles:
![]() |
D. P Macfarlane, S. Forbes, and B. R Walker Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome J. Endocrinol., May 1, 2008; 197(2): 189 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Bujalska, K. N. Hewitt, D. Hauton, G. G. Lavery, J. W. Tomlinson, E. A. Walker, and P. M. Stewart Lack of Hexose-6-Phosphate Dehydrogenase Impairs Lipid Mobilization from Mouse Adipose Tissue Endocrinology, May 1, 2008; 149(5): 2584 - 2591. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Wake, R. H. Stimson, G. D. Tan, N. Z. M. Homer, R. Andrew, F. Karpe, and B. R. Walker Effects of Peroxisome Proliferator-Activated Receptor-{alpha} and -{gamma} Agonists on 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in Subcutaneous Adipose Tissue in Men J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1848 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Wake, N. Z. M. Homer, R. Andrew, and B. R. Walker Acute In Vivo Regulation of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity by Insulin and Intralipid Infusions in Humans J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4682 - 4688. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Darmon, F. Dadoun, S. Boullu-Ciocca, M. Grino, M.-C. Alessi, and A. Dutour Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E995 - E1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Foster, M. B. Solomon, K. L. Huhman, and T. J. Bartness Social defeat increases food intake, body mass, and adiposity in Syrian hamsters Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1284 - R1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hershberger, M. R. McCammon, J. P. Garry, M. T. Mahar, and R. C. Hickner Responses of Lipolysis and Salivary Cortisol to Food Intake and Physical Activity in Lean and Obese Children J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4701 - 4707. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Sandoval, L. Ping, R. A. Neill, S. Morrey, and S. N. Davis The Effects of Dehydroepiandrosterone Sulfate on Counterregulatory Responses During Repeated Hypoglycemia in Conscious Normal Rats Diabetes, March 1, 2004; 53(3): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393. [Abstract] [Full Text] |
||||
![]() |
M. F. Nielsen, A. Caumo, V. Chandramouli, W. C. Schumann, C. Cobelli, B. R. Landau, H. Vilstrup, R. A. Rizza, and O. Schmitz Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E102 - E110. [Abstract] [Full Text] |
||||
![]() |
M. van der Valk, P. Reiss, F. C. van Leth, M. T. Ackermans, E. Endert, J. A. Romijn, R. Heijligenberg, and H. Sauerwein Highly Active Antiretroviral Therapy-Induced Lipodystrophy Has Minor Effects on Human Immunodeficiency Virus-Induced Changes in Lipolysis, but Normalizes Resting Energy Expenditure J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5066 - 5071. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. D. Riis, C. H. Gravholt, C. B. Djurhuus, H. Norrelund, J. O. L. Jorgensen, J. Weeke, and N. Moller Elevated Regional Lipolysis in Hyperthyroidism J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4747 - 4753. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Sekhar, F. Jahoor, A. C. White, H. J. Pownall, F. Visnegarwala, M. C. Rodriguez-Barradas, M. Sharma, P. J. Reeds, and A. Balasubramanyam Metabolic basis of HIV-lipodystrophy syndrome Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E332 - E337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Djurhuus, C. H. Gravholt, S. Nielsen, A. Mengel, J. S. Christiansen, O. E. Schmitz, and N. Moller Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E172 - E177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meijssen, R. J. Derksen, S. Bilecen, D. W. Erkelens, and M. C. Cabezas In Vivo Modulation of Plasma Free Fatty Acids in Patients with Familial Combined Hyperlipidemia Using Lipid-Lowering Medication J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1576 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meijssen, M. C. Cabezas, C. G. M. Ballieux, R. J. Derksen, S. Bilecen, and D. W. Erkelens Insulin Mediated Inhibition of Hormone Sensitive Lipase Activity in Vivo in Relation to Endogenous Catecholamines in Healthy Subjects J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4193 - 4197. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Punyadeera, M-T. van der Merwe, N. J. Crowther, M. Toman, G. P. Schlaphoff, and I. P. Gray Ethnic differences in lipid metabolism in two groups of obese South African women J. Lipid Res., May 1, 2001; 42(5): 760 - 767. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |